Array biopharma announces fda acceptance for review of binimetinib and encorafenib new drug applications for patients with advanced braf-mutant melanoma

13th September 2017 Uncategorised 0

Array BioPharma

More: Array biopharma announces fda acceptance for review of binimetinib and encorafenib new drug applications for patients with advanced braf-mutant melanoma
Source: MDlinx